Marker Therapeutics EPS Basic from Accounting Change (Quarterly) Analysis

Marker Therapeutics, Inc. (MRKR)

2.21 +0.09 (+4.25%) USD | NASDAQ | Jan 21, 12:07

View EPS Basic from Accounting Change (Quarterly) for MRKR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Accounting Change (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Accounting Change (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Accounting Change (Quarterly) Benchmarks

Start Trial

Viridian Therapeutics, Inc.	--
ADMA Biologics, Inc.	--
Kiniksa Pharmaceuticals International Plc	--
Neurocrine Biosciences, Inc.	--
AIM ImmunoTech, Inc.	--